Physician profile
Adele E Broussard
NPI 1972118842
$699.20
in general payments reported to CMS, 2019-2025
14 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $304 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $187.04 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Astrazeneca Pharmaceuticals Lp | $131.80 | 2024 | Farxiga |
| Lilly USA, LLC | $69.22 | 2024-2025 | Zepbound, Mounjaro |
| Abbvie INC. | $62.37 | 2024-2025 | |
| Insulet Corporation | $34.14 | 2024-2025 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.32 | 2025 | Jardiance |
| Rgh Enterprises LLC | $28.94 | 2025 | |
| Dexcom, INC. | $27.04 | 2024 | Dexcom G6 Transmitter |
| Sequel Med Tech, LLC | $24.68 | 2025 | Twiist |
| Corcept Therapeutics | $24.11 | 2025 | Korlym |
| Janssen Pharmaceuticals, INC | $24.00 | 2025 | Spravato |
| Novo Nordisk INC | $20.14 | 2025 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $18.00 | 2025 | |
| Vanda Pharmaceuticals INC. | $14.40 | 2025 | Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adele Broussard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.